Press release
Macrolide Antibiotics Market Expert Financial Overview | Success Milestones | Top Players Revenue and Forecasts by 2023
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) - Global Forecast till 2023Market Synopsis of the Global Macrolide Antibiotics Market
Market Scenario
Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea. They inhibit protein synthesis in bacteria by binding to the 50S ribosomal element and effective against gram positive bacteria and intracellular pathogens such as Legionella, Mycoplasma, and Chlamydia. It primarily act as a bacteriostatic agent against many strains of Corynebacteria, Listeria, Moxicella, Streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp.
The market of macrolide antibiotics exhibits a significant growth across the globe owing to the increasing prevalence of skin infections and growing demand for drugs against bacterial skin infections.
Major concerns involved in the use of macrolide antibiotics are GI disturbances and inhibition of hepatic metabolism. According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the review period.
The global macrolide antibiotics market is expected to grow at a CAGR of 12.5% during the forecast period from 2017-2023.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4331
Key Players in the Global Macrolide antibiotics Market
Some of the key players in this market are Merck Sharp & Dohme Corp (U.S.), Pfizer Inc. (U.S.), Neo Química (Brazil), Macrolide Pharmaceuticals (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Fresenius Kabi USA (U.S.), Sandoz International GmbH (Germany), Gland Pharma Limited (India), Mylan N.V. (U.S.),and WOCKHARDT (U.S.)
Segments
The global macrolide antibiotics market is segmented on the basis of drugs which includes azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin.
On the basis of route of administration, the market is segmented into oral and parenteral.
On the basis of indication, the market is segmented into infection due to mycoplasma pneumoniae, legionella sp, or bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, peliosis hepatis in patients with AIDS, cerebral toxoplasmosis, uncomplicated skin infections, and others.
On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmaceutical companies, and others.
Obtain Report Details @ https://www.marketresearchfuture.com/reports/macrolide-antibiotics-market-4342
Major TOC for Macrolide Antibiotics Market Research Report – Forecast to 2023
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC Continued….!
Get Discount @ https://www.marketresearchfuture.com/check-discount/4331
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Macrolide Antibiotics Market Expert Financial Overview | Success Milestones | Top Players Revenue and Forecasts by 2023 here
News-ID: 1152998 • Views: …
More Releases from Market Research Future
5G Fixed Wireless Access Market Estimated at USD 19.15 Billion in 2024, Projecte …
The 5G Fixed Wireless Access (FWA) Market is witnessing exponential growth, driven by the increasing demand for high-speed internet and wireless broadband solutions.
Valued at USD 19.15 Billion in 2024, the market is projected to reach USD 424.68 Billion by 2035, exhibiting a CAGR of 32.54% during the forecast period 2025-2035. The adoption of 5G technology, expansion of network infrastructure, and rising data consumption are fueling market growth globally.
Competitive Landscape:
Key…
Photonics Market Climbs to USD 764.3 Billion in 2024; Forecast Shows Expansion t …
The Photonics Market is witnessing strong growth driven by rising adoption of photonics technologies across healthcare, telecommunications, defense, and manufacturing sectors.
The market was valued at USD 764.3 Billion in 2024 and is projected to reach USD 1,693.75 Billion by 2035, exhibiting a CAGR of 7.5% during the forecast period 2025-2035. Innovations in laser technology, optical sensors, imaging systems, and fiber optics are fueling market expansion globally.
Competitive Landscape:
Key players operating…
Smart TV Market Estimated at USD 245,210.2 Million in 2024, Projected to Reach U …
The Smart TV Market is witnessing significant growth due to increasing consumer preference for connected entertainment devices, rising internet penetration, and demand for streaming services.
The market was valued at USD 245,210.2 Million in 2024 and is projected to reach USD 1,068,791.57 Million by 2035, exhibiting a CAGR of 14.32% during the forecast period 2025-2035.
Technological advancements, including OLED, QLED, 4K/8K resolution, AI integration, and smart home compatibility, are further driving…
Electronic Toll Collection Market Size Reaches USD 9.4 Billion in 2024, Expected …
The Electronic Toll Collection Market is witnessing steady growth due to increasing adoption of automated tolling systems, government initiatives for smart transportation infrastructure, and growing demand for cashless and efficient toll operations.
The market was valued at USD 9.4 Billion in 2024 and is projected to reach USD 17.99 Billion by 2035, exhibiting a CAGR of 6.08% during the forecast period 2025-2035.
Rising traffic congestion, need for faster toll collection, and…
More Releases for Macrolide
Rising Prevalence Of Skin Infections Fuels Growth In The Macrolide Antibiotics M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Macrolide Antibiotics Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a quick expansion in the market size of macrolide antibiotics. It is projected to surge from $59.07 billion in 2024 to $66.02 billion in 2025, with a Compound Annual Growth Rate (CAGR)…
Macrolide Drugs Market: A Comprehensive Overview
The global macrolide drugs market was valued at approximately USD 5.60 billion in 2024 and is expected to reach around USD 6.82 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.0% from 2025 to 2033.
Macrolide Drugs Market Overview
Macrolide antibiotics, including azithromycin, clarithromycin, and erythromycin, are widely used in the treatment of respiratory tract infections, skin infections, and sexually transmitted diseases. Their broad-spectrum activity and favorable safety…
Emerging Macrolide Antibiotics Market Trend 2025-2034: Growing Emphasis On Gener …
"How Is the Macrolide Antibiotics Market Projected to Grow, and What Is Its Market Size?
The market size for macrolide antibiotics has seen a swift expansion in the past few years. It is expected to elevate from a value of $59.07 billion in 2024 to $66.02 billion in 2025, marking a compound annual growth rate (CAGR) of 11.8%. The preceding period's growth is associated with factors like escalating antibiotic resistance, authorization…
Defending Health: Global Macrolide Antibiotics Market Analysis 2023-2031
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Macrolide antibiotics have long been stalwarts in the fight against bacterial infections, offering potent and versatile solutions to a wide range of ailments. As the world faces evolving challenges in infectious disease management, the global macrolide antibiotics market is poised to undergo significant growth, driven by technological advancements, increasing antibiotic resistance, and the impact of the COVID-19 pandemic.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
…
Macrolide Antibiotics Market Greater Revenue Share by 2026(Macrolide Antibiotics …
Macrolide Antibiotics are bacteriostatic in nature with a broad spectrum of activity against many gram-positive bacteria. Macrolide Antibiotics are primarily useful in treating soft tissue, respiratory condition, sexually transmitted and atypical mycobacterial infections. Macrolide Antibiotics also possess anti-inflammatory and immunomodulatory effects which are used for certain health conditions. Macrolide Antibiotics are considered to be both first line and second line of treatment, it mainly depends on the conditions it is…
Macrolide Antibiotics Market Report 2018 - GlaxoSmithKline, Johnson & Johnson, B …
An exclusive Macrolide Antibiotics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Macrolide Antibiotics Market By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), By Route of Administration (Oral, Parenteral), By Infection (Mycoplasma pneumoniae, Legionella sp., Or Bordetella pertussis,Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis, Uncomplicated Skin Infections), By End User (Hospital,…
